MAV BEAUTY BRANDS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

• Total revenue of $19.3 million versus $21.1 million in Q1 2022
• Adjusted EBITDA⁽¹⁾ of $1.3 million versus $2.9 million in Q1 2022
• Net loss of $3.9 million compared to a net loss of $0.6 million in Q1 2022
• Adjusted Net Income (Loss) ⁽¹⁾ of ($2.4) million versus Adjusted Net Income of $0.1 million in Q1 2022

VAUGHAN, ON, May 11, 2023 /CNW/ - MAV Beauty Brands Inc. ("MAV Beauty Brands" or the "Company"), a global personal care company, today announced its financial results for the three months ended March 31, 2023. Unless otherwise indicated, all amounts are expressed in U.S. dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS measures (see "Non-IFRS Measures" below).

"Our sales results for the first quarter reflect the continuing impact of distribution losses and broader macroeconomic challenges, notably higher interest rates," said Serge Jureidini, President & CEO of MAV Beauty Brands. "While we continue to have areas of strength across the portfolio, including solid performance from our largest brand, our team is focused on the execution of our strategies to strengthen each of the brands, with an emphasis on product innovation and marketing. At the same time, we continue to advance our ongoing cost saving initiatives, which we believe will positively impact gross margins and operating profitability."

Selected Financial Highlights⁽¹⁾⁽²⁾

(in thousands of US dollars except per share amounts) (unaudited)	Q1 2023	Q1 2022
Revenue	19,255	21,137
Gross profit	7,839	9,317
Net (loss) for the period	(3,869)	(632)
Loss per Share (basic)	(0.10)	(0.02)
Adjusted EBITDA	1,282	2,873
Cash flow (use) from operating activities	(63)	3,728
Free Cash Flow and Adjusted Free Cash Flow	(108)	3,681
Adjusted Net Income (Loss)	(2,386)	86

(1)

EBITDA (used below), Adjusted EBITDA, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Net Income (Loss), Adjusted Net Income (Loss) per Share (diluted), and Net Debt (used below) are each non-IFRS measures and are not earning measures recognized by IFRS. Further information about non-IFRS measures and definitions of the non-IFRS measures used in this press release can be found under the heading "Non-IFRS Measures" in this press release. Reconciliations of non-IFRS measures to the relevant reported measures prepared in accordance with IFRS can be found in this press release under the headings "Q1 2023 Compared to Q1 2022". See also the heading "How We Assess the Performance of Our Business" on page 7, and the heading "Non-IFRS Measures" on page 9 of our Management's Discussion and Analysis for the three-month period ended March 31, 2023.

(2)

Earnings per share (basic) calculation does not include the impact of 2,463,963 common shares of the Company issuable upon the exchange of the units issued as part of The Mane Choice acquisition.

Q1 2023 Business and Financial Review 

Q1 2023 total revenue was $19.3 million, compared to $21.1 million in Q1 2022. For the Canada/US region, revenue decreased by 9.3% to $18.0 million in Q1 2023, compared to $19.9 million in Q1 2022. For the International region, revenue was $1.2 million, compared to $1.3 million in Q1 2022. Revenue decreases year over year principally reflect the impact of loss of distribution in the US mass and drug channels.

Gross profit was $7.8 million in Q1 2023 (40.7% margin), compared to $9.3 million (44.1% margin) reported in Q1 2022. The lower gross profit margin in Q1 2023 mainly reflects the impact of sales mix in the quarter, as well as increased supply chain input costs. The Company continues to closely monitor the impact of inflation on supply chain input costs, and is implementing select price increases and procurement cost savings initiatives.

Adjusted EBITDA⁽¹⁾ decreased to $1.3 million in Q1 2023, from $2.9 million in Q1 2022, mainly due to lower revenue and gross margin.

In Q1 2023, the Company reported a net loss of $3.9 million, versus a net loss of $0.6 million in Q1 2022. As a result of the changes in the interest rate and payment terms in the Q1 2023 amendment and extension of its credit facilities, the Company recalculated the carrying amount of the total obligation and recorded a loss on modification totaling $1.5 million in the quarter.

Adjusted Net Income (Loss) ⁽¹⁾ for Q1 2023 was ($2.4) million, compared with Adjusted Net Income of $0.1 million in Q1 2022, due to the factors discussed above.

Cash from operating activities was a loss of $0.1 million in Q1 2023, a decrease from positive $3.7 million in Q1 2022, reflecting lower Adjusted EBITDA and higher cash interest. Adjusted Free Cash Flow⁽¹⁾ decreased to a net use of $0.1 million in Q1 2023, compared to $3.7 million in Q1 2022.

At quarter end, Cash was $8.3 million and Net Debt⁽¹⁾ was $115.6 million, compared with $115.0 as at December 31, 2022. As previously disclosed with its fiscal 2022 financial results, MAV initiated a strategic review process to identify, review and evaluate potential strategic alternatives that may be available to the Company and amended and extended its credit facilities in March 2023. The amended and extended credit facilities are available under the Company's profile at www.sedar.com and are described in our Management's Discussion and Analysis for the three months ended March 31, 2023. See "Forward-Looking Information".

Financial Statements and Management's Discussion and Analysis

The Company's unaudited condensed consolidated interim financial statements for the three months ended March 31, 2023 are available under the Company's profile on SEDAR at www.sedar.com and on MAV Beauty Brands' investor relations website at investors.mavbeautybrands.com.

Conference Call & Webcast

MAV Beauty Brands will host a conference call to discuss its fiscal 2023 first quarter financial results at 8:30 a.m. EDT on May 11, 2023. To participate in the call, dial 416-764-8650 or 888-664-6383 using the conference ID 58689724. The audio webcast can be accessed at investors.mavbeautybrands.com.Listeners should access the webcast or call 10-15 minutes before the start time to ensure they are connected.

About MAV Beauty Brands (TSX:MAV)

MAV Beauty Brands is a global personal care platform focused on managing great independent brands to scale and win market share through product innovation, marketing and expanded distribution. Today, MAV Beauty Brands markets a diversified portfolio of four complementary personal care brands – Marc Anthony True Professional, Renpure, Cake Beauty and The Mane Choice – offering premium quality hair care, face and body care beauty products. These products are sold in over 25 countries around the world and in many major retailers.

Non–IFRS Measures

This press release makes reference to certain non–IFRS measures. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. We use non–IFRS measures including "Adjusted Net Income (Loss) Per Share (Diluted)", "Adjusted EBITDA", "Adjusted Free Cash Flow", "Adjusted Net Income (Loss)", "EBITDA", "Free Cash Flow" and "Net Debt". These non–IFRS measures are used to provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. We also believe that securities analysts, investors, and other interested parties frequently use non–IFRS measures in the evaluation of issuers. Our management also uses non–IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and to determine components of management compensation. Definitions and reconciliations of non-IFRS measures to the relevant reported measures prepared in accordance with IFRS can be found under the headings "Non-IFRS Measures" and "Q1 2023 Compared to Q1 2022" in this press release. See also our Management's Discussion and Analysis under the headings "How We Assess the Performance of Our Business" on page 7, and "Non-IFRS Measures" on page 9.

"Adjusted Net Income (Loss) Per Share (Diluted)" is computed similarly to basic earnings per share except that the weighted average number of shares outstanding is increased to include additional shares for the assumed conversion of preference shares, proportionate voting shares, and exchangeable shares and exercise of stock options, if dilutive. The average number of shares is calculated by assuming that outstanding conversions were exercised and that the proceeds from such exercises were used to acquire common shares at the average market price during the reporting period. We believe Adjusted Net Income (Loss) Per Share (Diluted) is a useful measure to assess the performance of our Company as it provides meaningful operating results per diluted share and facilitates period-to-period operating comparisons.

"Adjusted EBITDA" represents, for the applicable period, EBITDA before certain expenses, costs, charges or benefits incurred in such period which in management's view are not indicative of continuing operations, including: (i) integration, restructuring, and other costs; (ii) purchase accounting adjustments; (iii) share–based compensation; (iv) impairment of goodwill; and (v) unrealized foreign exchange (loss) gain. We believe Adjusted EBITDA is a useful measure to assess the performance of our Company as it provides meaningful operating results and facilitates period-to-period operating comparisons.

"Adjusted Free Cash Flow" is calculated as Free Cash Flow adjusted to add back acquisition related costs which are included in cash provided by operating activities. We believe Adjusted free cash flow is a useful measure to assess the Company's ability to repay debt, finance strategic business acquisitions and investments, pay dividends and repurchase shares. It also facilitates period-to-period comparisons.

"Adjusted Net Income (Loss)" represents, for the applicable period, net income (loss) as adjusted to add back or deduct, as applicable, certain expenses, costs, charges or benefits incurred in such period which in management's view are not indicative of continuing operations, including: (i) integration, restructuring, and other costs; (ii) purchase accounting adjustments; (iii) share–based compensation; (iv) impairment of goodwill; (v) unrealized foreign exchange loss (gain); and (vi) tax impacts of the aforementioned adjustments (based on annual effective tax rate). We believe Adjusted Net Income (Loss) is a useful measure to assess the performance of our Company as it provides meaningful operating results and facilitates period-to-period operating comparisons.

"EBITDA" represents net income (loss) for the period before: (i) income tax expense (recovery); (ii) interest and accretion; and (iii) amortization and depreciation.

''Free Cash Flow'' represents, for the applicable period, cash provided by operating activities less cash used to purchase property and equipment. Free cash flow is a key metric used by the investing community that measures the Company's ability to repay debt, finance strategic business acquisitions and investments, pay dividends and repurchase shares.

"Net Debt" is calculated as long-term debt before unamortized deferred financing costs less cash as reported in the consolidated statements of financial position. We believe Net Debt is a useful measure is an important measure as it reflects the principal amount of debt owing by the Company as at a particular date.

Forward-Looking Information
Certain information in this press release, including the Company's expectation to strengthen its brands, to achieve ongoing costs savings initiatives, to identify and solicit strategic alternatives as part of the strategic review process, relating to the realization of any strategic transaction and the timing and terms thereof, and challenging macroeconomic conditions generally constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events.

The Board of Directors has previously announced that it initiated a strategic review process to identify, review and evaluate potential strategic alternatives that may be available to the Company, including without limitation, the sale of all or substantially all of the Company's securities and/or its assets, or the raising of additional debt or equity capital. The Board has engaged Piper Sandler & Co. as its financial advisor to assist with identifying and soliciting strategic alternatives. It is the Company's current intention not to disclose developments with respect to the strategic review process unless and until the Board has approved a specific transaction or otherwise determines that disclosure is necessary or appropriate. There can be no assurances or guarantees that the strategic review process will result in a transaction or, if a transaction is undertaken, the terms or timing of such a transaction.

The terms of the credit facilities require the Company to satisfy many affirmative and negative covenants and to meet certain financial tests, including minimum Adjusted EBITDA and minimum liquidity covenants, as more particularly described in the credit facilities. In addition, the Company has agreed to launch the aforementioned strategic review process by May 31, 2023, in accordance with a plan (including key milestone dates) approved by the lenders. The Company has required several amendments and extensions from its lenders over the past eight months, and there is no assurance that we will be able to meet the minimum Adjusted EBITDA and minimum liquidity targets that we are required to achieve, and/or to deliver or launch a strategic review plan that is satisfactory to the lenders, in each case, to remain in compliance with the foregoing covenants, among others. There can be no assurances or guarantees that the approved strategic review plan will result in a transaction or, if a transaction is undertaken, the terms or timing of such a transaction. A failure by us to comply with the covenants specified in the credit facilities could result in an event of default, which would give the lenders the right to declare all borrowings outstanding, together with accrued and unpaid interest and fees, to be immediately due and payable. If the debt under the credit facilities were to be accelerated, it is unlikely that the Company would be able to repay (or refinance) the accelerated indebtedness (including by way of selling sufficient assets) or fulfill its obligations under certain contracts, and its future financial condition, results of operations, prospects and/or cashflows would be materially adversely affected. In such a situation the Company would need to seek an additional amendment or waiver of such covenants. The lenders under the credit facilities may not consent to any amendment or waiver request that the Company may make, and, if they do consent, they may only do so on terms that are unfavorable or costly to the Company, and shareholders may consequently lose some or all of their investment.

Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by MAV Beauty Brands as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the "Risk Factors" section of the Company's most recently filed Annual Information Form, the "Risk Factors" section of the Company's most recently filed MD&A, and the Company's other periodic filings made available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect MAV Beauty Brands; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and MAV Beauty Brands expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Q1 2023 Compared to Q1 2022

	(in thousands of US dollars) (unaudited)		Q1 2023				Q1 2022				$ Change				% Change
	Consolidated statements of operations:
	Revenue			19,255				21,137				(1,882)				(8.9)	%
	Cost of sales			11,416				11,820				(404)				(3.4)	%
	Gross profit			7,839				9,317				(1,478)				(15.9)	%
	Expenses
	Selling and administrative			6,867				6,725				142				2.1	%
	Loss on modification of term loan			1,502				—				1,502			nmf
	Amortization and depreciation			776				1,100				(324)				(29.5)	%
	Interest and accretion			2,385				1,691				694				41.0	%
	Foreign exchange gain			(36)				68				(104)				(152.9)	%
	Integration, restructuring, and other			214				615				(401)				(65.2)	%
				11,708				10,199				1,509			nmf
	Loss before income taxes			(3,869)				(882)				(2,987)			nmf
	Income tax expense (recovery)
	Deferred			—				(250)				250			nmf
				—				(250)				250			nmf
	Net loss for the period			(3,869)				(632)				(3,237)			nmf
	EBITDA ^(1)			(708)				1,909				(2,617)			nmf
	Adjusted EBITDA ^(1)			1,282				2,873				(1,591)				(55.4)	%
	Adjusted Net Income (Loss) ^(1)			(2,386)				86				(2,472)			nmf

(1)

EBITDA, Adjusted EBITDA and Adjusted Net Income (Loss) are each non-IFRS measures and are not earning measures recognized by IFRS. Definitions and reconciliations of non-IFRS measures to the relevant reported measures can be found under the headings "Non-IFRS Measures" and "Q1 2023 Compared to Q1 2022" in this press release. See also our Management's Discussion and Analysis under the headings "How We Assess the Performance of Our Business" on page 7, and "Non-IFRS Measures" on page 9.

(in thousands of US dollars) (unaudited)		Q1 2023			Q1 2022
Consolidated net income (loss):		(2,367)			(632)
Income tax expense (recovery)		—			(250)
Interest and accretion		2,385			1,691
Amortization and depreciation		776			1,100
EBITDA		794			1,909
Integration, restructuring, and other	(1)	214			615
Share-based compensation	(2)	265			263
Unrealized foreign exchange loss		9			86
Adjusted EBITDA		1,282			2,873
(in thousands of US dollars) (unaudited)			Q1 2023				Q1 2022
Consolidated net income (loss):			(2,367)				(632)
Integration, restructuring, and other		(1)	214				615
Share-based compensation		(2)	265				263
Unrealized foreign exchange loss			9				86
Tax impact of the above adjustments			(124)				(246)
Adjusted Net Income (Loss)			(2,003)				86

(1)	Refer to Note 10 to the unaudited condensed consolidated interim financial statements for further details.
(2)	Represents recognition of share-based compensation, which have been accounted for as selling and administrative expenses.

(in thousands of US dollars) (unaudited)		Q1 2023		Q1 2022		YTD Q1 2023		YTD Q1 2022
Cash provided by operating activities		(66)		3,728		(66)		3,728
Less: purchase of property and equipment		(42)		(47)		(42)		(47)
Free Cash Flow and Adjusted Free Cash Flow		(108)		3,681		(108)		3,681

SOURCE MAV Beauty Brands

Craig Armitage, Investor Relations, [email protected], [phone]